Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. 1989

E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
West Midlands Cancer Research Campaign Clinical Trials Unit, Birmingham, England.

We report a phase II study of bleomycin, ifosfamide, and cisplatin (BIP) in cervical cancer. Our aims were to assess response rate, toxicity, and survival in women treated with this combination. Among 49 patients, 34 objective responses (69%) were seen, with 10 complete responses (20%). Toxic effects were assessed in 186 treatment cycles. All patients had alopecia and nausea and vomiting. Other effects included myelosuppression, infection, reduction in renal function, and disturbance of consciousness. These data indicate that BIP is highly active against advanced and recurrent cervical cancer.

UI MeSH Term Description Entries
D007069 Ifosfamide Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. Isofosfamide,Isophosphamide,Asta Z 4942,Holoxan,Iphosphamide,Iso-Endoxan,NSC-109,724,NSC-109724,Iso Endoxan,NSC 109,724,NSC 109724,NSC109,724,NSC109724
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
January 1990, Cancer chemotherapy and pharmacology,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
June 1984, Cancer treatment reports,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
November 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
March 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
April 1992, Seminars in oncology,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
August 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
July 1991, Gynecologic oncology,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
December 2004, The Tohoku journal of experimental medicine,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
May 1989, Nihon Sanka Fujinka Gakkai zasshi,
E J Buxton, and C A Meanwell, and C Hilton, and J J Mould, and D Spooner, and A Chetiyawardana, and T Latief, and M Paterson, and C W Redman, and D M Luesley
August 1997, The Journal of urology,
Copied contents to your clipboard!